ViiV Healthcare Company et al v. Zydus Pharmaceuticals (USA) Inc. et al
| ViiV Healthcare Company, Shionogi & Co., Ltd. and ViiV Healthcare UK (No.3) Limited |
| Zydus Pharmaceuticals (USA) Inc., Zydus Lifesciences Global FZE and Zydus Lifesciences Limited |
| 1:2025cv01520 |
| December 17, 2025 |
| U.S. District Court for the District of Delaware |
| Gregory B Williams |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. § 1 Patent Infringement |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on May 28, 2026. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Pro Hac Vice Attorney Hannah J. Thomas for Zydus Lifesciences Global FZE, Zydus Lifesciences Limited & Zydus Pharmaceuticals (USA) Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (slk) |
| Pro Hac Vice Attorney Michael J. Gaertner for Zydus Lifesciences Global FZE, Zydus Lifesciences Limited & Zydus Pharmaceuticals (USA) Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (slk) |
| Pro Hac Vice Attorney Nina Vachhani for Zydus Lifesciences Global FZE, Zydus Lifesciences Limited, and Zydus Pharmaceuticals (USA) Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) |
| Pro Hac Vice Attorney Zhibin Li for Zydus Lifesciences Global FZE, Zydus Lifesciences Limited, and Zydus Pharmaceuticals (USA) Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) |
SO ORDERED, re #25 STIPULATION TO EXTEND TIME the deadline for the Parties to submit a Proposed Scheduling Order to June 17, 2026 filed by ViiV Healthcare UK (No.3) Limited, ViiV Healthcare Company, Shionogi & Co., Ltd. Signed by Judge Gregory B. Williams on 5/12/2026. (lnb)
|
| Filing 25 STIPULATION TO EXTEND TIME the deadline for the Parties to submit a Proposed Scheduling Order to June 17, 2026 - filed by Shionogi & Co., Ltd., ViiV Healthcare Company, ViiV Healthcare UK (No.3) Limited. (Joyce, Alexandra) |
|
SO ORDERED, re #23 MOTION for Pro Hac Vice Appearance of Attorney Zhibin Li filed by Zydus Lifesciences Global FZE, Zydus Pharmaceuticals (USA) Inc., Zydus Lifesciences Limited. Signed by Judge Gregory B. Williams on 5/7/2026. (lnb)
|
|
SO ORDERED, re #22 MOTION for Pro Hac Vice Appearance of Attorney Nina Vachhani filed by Zydus Lifesciences Global FZE, Zydus Pharmaceuticals (USA) Inc., Zydus Lifesciences Limited. Signed by Judge Gregory B. Williams on 5/7/2026. (lnb)
|
| Filing 24 Pro Hac Vice Fee - Credit Card Payment received for Nina Vachhani and Zhibin Li. ( re #23 MOTION for Pro Hac Vice Appearance of Attorney Zhibin Li, #22 MOTION for Pro Hac Vice Appearance of Attorney Nina Vachhani )( Payment of $ 100, receipt number BDEDC-4964207).(Koopman, Andrew) |
| Filing 23 MOTION for Pro Hac Vice Appearance of Attorney Zhibin Li - filed by Zydus Lifesciences Global FZE, Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc.. (Attachments: #1 Certification by Counsel to be admitted Pro Hac Vice)(Koopman, Andrew) |
| Filing 22 MOTION for Pro Hac Vice Appearance of Attorney Nina Vachhani - filed by Zydus Lifesciences Global FZE, Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc.. (Attachments: #1 Certification by Counsel to be admitted Pro Hac Vice)(Koopman, Andrew) |
|
SO ORDERED, re #19 MOTION for Pro Hac Vice Appearance of Attorney Jacob C. Britz filed by Zydus Lifesciences Global FZE, Zydus Pharmaceuticals (USA) Inc., Zydus Lifesciences Limited. Signed by Judge Gregory B. Williams on 5/6/2026. (lnb)
|
|
SO ORDERED, re #18 MOTION for Pro Hac Vice Appearance of Attorney Michael J. Gaertner filed by Zydus Lifesciences Global FZE, Zydus Pharmaceuticals (USA) Inc., Zydus Lifesciences Limited. Signed by Judge Gregory B. Williams on 5/6/2026. (lnb)
|
| Pro Hac Vice Attorney Jacob C. Britz for Zydus Lifesciences Global FZE, Zydus Lifesciences Limited & Zydus Pharmaceuticals (USA) Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (slk) |
|
SO ORDERED, re #20 MOTION for Pro Hac Vice Appearance of Attorney Hannah J. Thomas filed by Zydus Lifesciences Global FZE, Zydus Pharmaceuticals (USA) Inc., Zydus Lifesciences Limited. Signed by Judge Gregory B. Williams on 5/6/2026. (lnb)
|
| Filing 21 Pro Hac Vice Fee - Credit Card Payment received for Michael J. Gaertner, Jacob C. Britz, and Hannah J. Thomas. ( re #19 MOTION for Pro Hac Vice Appearance of Attorney Jacob C. Britz, #18 MOTION for Pro Hac Vice Appearance of Attorney Michael J. Gaertner, #20 MOTION for Pro Hac Vice Appearance of Attorney Hannah J. Thomas )( Payment of $ 150, receipt number BDEDC-4962319).(Koopman, Andrew) |
| Filing 20 MOTION for Pro Hac Vice Appearance of Attorney Hannah J. Thomas - filed by Zydus Lifesciences Global FZE, Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc.. (Attachments: #1 Certification by Counsel to be admitted Pro Hac Vice)(Koopman, Andrew) |
| Filing 19 MOTION for Pro Hac Vice Appearance of Attorney Jacob C. Britz - filed by Zydus Lifesciences Global FZE, Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc.. (Attachments: #1 Certification by Counsel to be admitted Pro Hac Vice)(Koopman, Andrew) |
| Filing 18 MOTION for Pro Hac Vice Appearance of Attorney Michael J. Gaertner - filed by Zydus Lifesciences Global FZE, Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc.. (Attachments: #1 Certification by Counsel to be admitted Pro Hac Vice)(Koopman, Andrew) |
| Filing 17 NOTICE of Appearance by Andrew John Koopman on behalf of Zydus Lifesciences Global FZE, Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc. (Koopman, Andrew) |
|
Filing 16
ORAL ORDER: IT IS HEREBY ORDERED that, by no later than thirty (30) days from the date of this Order, the parties shall meet and confer and file a joint proposed Scheduling Order in this action consistent with the applicable form Scheduling Order of Judge Williams, which is posted at http://www/ded/uscourts.gov (See Chambers, Judge Williams, Forms), along with a cover letter requesting the Court to enter the joint proposed Scheduling Order (if there are no disputes or other issues concerning scheduling that the Court needs to address) or to schedule the Scheduling Conference. If there are disputes or other issues the Court needs to address in the joint proposed Scheduling Order, in the cover letter, the parties shall direct the Court to the paragraph numbers in the joint proposed Scheduling Order which those appear. Parties should also send a WORD version of the joint proposed Scheduling Order to [email protected]. ORDERED by Judge Gregory B. Williams on 4/16/2026. (lnb)
|
| Filing 15 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Zydus Lifesciences Limited for Zydus Lifesciences Global FZE, Zydus Pharmaceuticals (USA) Inc. filed by Zydus Lifesciences Global FZE, Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc.. (Blaszkowski, Christopher) |
| Filing 14 ANSWER to #1 Complaint, by Zydus Lifesciences Global FZE, Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc..(Blaszkowski, Christopher) |
|
SO ORDERED, re #13 STIPULATION TO EXTEND TIME to move, plead, or otherwise respond to the Complaint to March 17, 2026 filed by Zydus Lifesciences Global FZE, Zydus Pharmaceuticals (USA) Inc., Zydus Lifesciences Limited, Reset Answer Deadlines: All Defendants. Signed by Judge Gregory B. Williams on 1/8/2026. (lnb)
|
| Filing 13 STIPULATION TO EXTEND TIME to move, plead, or otherwise respond to the Complaint to March 17, 2026 - filed by Zydus Lifesciences Global FZE, Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc.. (Blaszkowski, Christopher) |
| Filing 12 WAIVER OF SERVICE returned executed by ViiV Healthcare Company, Shionogi & Co., Ltd., ViiV Healthcare UK (No.3) Limited: For Zydus Pharmaceuticals (USA) Inc. waiver sent on 12/17/2025, answer due 3/17/2026. (Silver, Daniel) |
| Filing 11 WAIVER OF SERVICE returned executed by ViiV Healthcare Company, Shionogi & Co., Ltd., ViiV Healthcare UK (No.3) Limited: For Zydus Lifesciences Limited waiver sent on 12/17/2025, answer due 3/17/2026. (Silver, Daniel) |
| Case Assigned to Judge Gregory B. Williams. Please include the initials of the Judge (GBW) after the case number on all documents filed. (alb) |
| CORRECTING ENTRY: The main pdf at D.I. #9 has been replaced with the correct version. The NEF for D.I. #9 has been regenerated. (nms) |
| Filing 10 DECLARATION of Service for Zydus Lifesciences Limited by Shionogi & Co., Ltd., ViiV Healthcare Company, ViiV Healthcare UK (No.3) Limited. (Attachments: #1 Exhibit A-B)(Joyce, Alexandra) |
| Filing 9 DECLARATION of Service for Zydus Lifesciences Global FZE by Shionogi & Co., Ltd., ViiV Healthcare Company, ViiV Healthcare UK (No.3) Limited. (Attachments: #1 Exhibit A-B)(Joyce, Alexandra) (Main Document 9 replaced on 12/22/2025) (nms). |
| Filing 8 DECLARATION of Service for Zydus Pharmaceuticals (USA) Inc. by Shionogi & Co., Ltd., ViiV Healthcare Company, ViiV Healthcare UK (No.3) Limited. (Attachments: #1 Exhibit A-B)(Joyce, Alexandra) |
| Filing 7 Summons Issued as to Zydus Lifesciences Global FZE on 12/17/2025; Zydus Lifesciences Limited on 12/17/2025; Zydus Pharmaceuticals (USA) Inc. on 12/17/2025. (Attachments: #1 Summons Issued, #2 Summons Issued)(cdd) |
| Filing 6 Disclosure Statement pursuant to Rule 7.1 identifying: Corporate Parent ViiV Healthcare Limited for ViiV Healthcare Company; Other Affiliates ViiV Healthcare Company, ViiV Healthcare UK Limited, and ViiV Healthcare Limited for ViiV Healthcare UK (No.3) Limited; Corporate Parent GlaxoSmithKline Mercury Limited, PHIVCO Luxembourg Sarl, PHIVCO Corp. and Shionogi B.V. for ViiV Healthcare Limited; Corporate Parent GSK plc. for GlaxoSmithKline Mercury Limited; Corporate Parent Pfizer, Inc. for PHIVCO Luxembourg Sarl and PHIVCO Corp.; and Corporate Parent Shionogi & Co. Ltd. for Shionogi B.V., filed by ViiV Healthcare Company, ViiV Healthcare UK (No.3) Limited. (cdd) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Shionogi & Co., Ltd. (cdd) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,242,986; 10,426,780. (cdd) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 11/4/2025. Date of Expiration of Patent(s): 9,242,986; 12/8/2029, with pediatric exclusivity through 6/8/2030. 10,426,780; 1/24/2031.Thirty Month Stay Deadline: No earlier than 5/4/2028. (cdd) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (cdd) |
| Filing 1 COMPLAINT for Patent Infringement against Zydus Lifesciences Global FZE, Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc. (Filing fee $ 405, receipt number ADEDC-4860854) - filed by ViiV Healthcare Company, Shionogi & Co., Ltd., ViiV Healthcare UK (No.3) Limited. (Attachments: #1 Civil Cover Sheet)(cdd) |
Access additional case information on PACER
Use the links below to access additional information about this case on the U.S. Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
